Oxobid Plus 0.3% Eye/Ear Drops
By Oxobid
10ml Eye/Ear Drops in a Packet

Composition
Ofloxacin(0.3% w/v)

Manufacturer - Astra Labs
B-2, S.K. Industrial Estate, S.V. Road, Mumbai - 400102, Maharashtra, India

Expires on or after
October, 2025

liver
The Oxobid Plus 0.3% Eye/Ear Drops do not have any known interactions with the liver. This means that there are no established risks or concerns specifically related to liver issues when using these drops. It is important to follow the recommended dosage and usage instructions provided with the drops. If you have any underlying liver conditions or concerns, it is advisable to consult with your healthcare provider before using the Oxobid Plus 0.3% Eye/Ear Drops. This will help ensure the safety and effectiveness of the treatment for your specific health needs.

kidney
No interaction has been found or established related to kidney issues with Oxobid Plus 0.3% Eye/Ear Drops. Consult with your doctor for proper guidance before using Oxobid Plus 0.3% Eye/Ear Drops.

alcohol
Consult your doctor when consuming alcohol with Oxobid Plus 0.3% Eye/Ear Drops.

driving
Caution should be taken when driving while using Oxobid Plus 0.3% Eye/Ear Drops as they may reduce alertness, impact vision, and cause drowsiness and dizziness. It is advised to avoid driving if these side effects occur.

pregnancy
Oxobid Plus 0.3% Eye/Ear Drops might not be safe during pregnancy. Animal studies suggest potential harm to the developing baby. Your doctor will assess benefits and risks before prescribing. Consult your doctor before use.

breastfeeding
Oxobid Plus 0.3% Eye/Ear Drops may not be safe while breastfeeding as there is a risk of the drug passing into breastmilk and causing harm to the baby.
Habit Forming | No |
Chemical Class | Fluoroquinolone |
Therapeutic Class | ANTI INFECTIVES |
Action Class | Quinolones/ Fluroquinolones |
₹20
Inclusive of all taxes
Content verified by

Dr. Preeti Kumar
MBBS, DGO - Obstetrics and Gynaecology, DNB - Obstetrics and Gynaecology
Last update on 01-Oct-2024